Health-IT Help for Personalized Medicine


By Allison Proffitt, Digital HealthCare & Productivity staff

November 18, 2008 | Personalized medicine can learn a lot from health-IT, said David Brailer at the Harvard-hosted Personalized Medicine: A Value Proposition conference last week. Brailer, the former “health-IT czar,” proposed that health-IT is about five years ahead of personalized medicine politically and culturally, and that the head start offers wisdom for personalized medicine.

Personalized medicine proponents need to recognize that the full value does not have to be understood by everyone, and really won’t be fully understood by the public, Brailer said. In order to grow, the health-IT movement had to educate experts to communicate with the public.

“We viewed health-IT as a campaign,” Brailer said of his early days as the national coordinator for health-IT at HHS. Brailer’s staff campaigned to Congressmen, governors, and anyone else that would listen, and he believes personalized medicine needs the same grassroots approach. “Personalized medicine needs that level of a war waged,” he said. “It’s not going to drift into the American consciousness.”

The second point Brailer carried from health-IT, is that the burden to prove superiority is on the innovator. Early health-IT efforts asked to be proven wrong, and that doesn’t work, he said. The benefits of personalized medicine must be shown in the real world, in real hospitals, under real conditions, and personalized medicine’s proponents must prove a strong case.

Besides just proving that it works, enthusiasts must show that it saves more money than it costs. Health-IT had to prove long term benefits in concrete amounts, and personalized medicine must do the same, which may be even more challenging in the current tight economic climate.

Finally, Brailer told the audience that they had to show doctors how personalized medicine would work for them in their clinics and hospitals. Just like training physicians to use an EMR, doctors will need to be helped through the change, and shown how to implement personalized medicine in their daily practice.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Thomson Reuters
The Rise of The Biologists: The Changing Face of The Bioinformatics Industry
Sponsored by Thomson Reuters


Intel
Transforming Large Scale Genomics and Collaborative Research
Sponsored by Intel


Avere
Considerations for Modernizing Scientific Compute Research Platforms
Sponsored by Avere


Life Science Webcasts & Podcasts

medidata_podcast_Sites and Sponsors: Mending Bridges over Troubled Waters  
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide

This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.

• Common ground in reaching agreement on a budget

• Improving the pace of agreement on budgets and contracts

• Processes for payment to sites on a timely basis

Listen Now  

More Podcasts

Job Openings

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.